WHO ICTRP trial
A Phase 1/2, Single-Center, Randomized, Placebo-Controlled, Double-Blind Study…
ACTRN12607000267459 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12607000267459 |
|---|---|
| Public title | A Phase 1/2, Single-Center, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in the Reduction or Eradication of Staphylococcus aureus Nasal Carriage among Adults |
| Scientific title | A Phase 1/2, Single-Center, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Topical Antimicrobial (NEO101) in the Reduction or Eradication of Staphylococcus aureus Nasal Carriage among Adults |
| Primary sponsor | Neosil, Inc. |
| Secondary sponsors | not applicable |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 / Phase 2 |
| Countries | Australia |
| Conditions | Stable nasal carriage of Staphylococcus aureus in adults; Stable nasal carriage of Staphylococcus aureus in adults;Infection - Studies of infection and infectious agents |
| Interventions | Eligible subjects will receive either 0.95% NEO101, which will be administered twice daily by topical application to the inside of each nostril, for a 7-day treatment course. A 14-day safety and efficacy assessment period will follow the… |
| Registration date | May 18, 2007 |
| Target size | 36 |
| Secondary IDs | Therapeutic Goods Association Clinical Trial Notification (TGA CTN): TGA CTN - 2007/246 (issued on 03/05/07) |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: